| scholarly article | Q13442814 |
| P50 | author | Kristen Johnson | Q44839395 |
| Hermann Kalhoff | Q64005991 | ||
| Patrick Schauerte | Q67186138 | ||
| P2093 | author name string | A Superti-Furga | |
| K Sano | |||
| R Terkeltaub | |||
| F Rutsch | |||
| H Kalhoff | |||
| W A Boisvert | |||
| B Maddux | |||
| S Vaingankar | |||
| I Goldfine | |||
| P2860 | cites work | Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome | Q22008705 |
| Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes | Q22010626 | ||
| Role of the mouse ank gene in control of tissue calcification and arthritis | Q22254612 | ||
| Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family | Q24308868 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL) | Q28142507 | ||
| Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities | Q28301252 | ||
| Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein | Q28304798 | ||
| Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine | Q28505453 | ||
| Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-1 (5'-nucleotide phosphodiesterase) | Q28589328 | ||
| Ecto-enzymes: physiology meets pathology | Q33873171 | ||
| Natural history of calcium deposits in atherosclerosis progression and regression | Q33894020 | ||
| Tech.sight. Genetic testing--present and future | Q34049724 | ||
| Idiopathic infantile arterial calcification: a case report and review of the literature | Q34261397 | ||
| Idiopathic infantile arterial calcification: unusual features | Q34268752 | ||
| Idiopathic infantile arterial calcification with cardiac, renal and central nervous system involvement | Q34521965 | ||
| Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. | Q40951338 | ||
| Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma | Q41104567 | ||
| Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. | Q42795833 | ||
| Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway | Q42798382 | ||
| Extracellular matrix calcification: where is the action? | Q46291249 | ||
| Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells | Q46831739 | ||
| Autotaxin, tumor motility-stimulating exophosphodiesterase | Q48055332 | ||
| Keutel syndrome: further characterization and review. | Q50504741 | ||
| Arthritis and ankylosis in twy mice with hereditary multiple osteochondral lesions: with special reference to calcium deposition. | Q50771981 | ||
| Low levels of urinary inorganic pyrophosphate indicating systemic pyrophosphate deficiency in a boy with idiopathic infantile arterial calcification. | Q52162692 | ||
| Identification of B10, an alkaline phosphodiesterase of the apical plasma membrane of hepatocytes and biliary cells, in rat serum: increased levels following bile duct ligation and during the development of cholangiocarcinoma. | Q53437411 | ||
| Molecular determinants of arterial calcification | Q64049906 | ||
| Idiopathic arterial calcification of infancy and pyrophosphate deficiency | Q70463159 | ||
| A soluble PC-1 circulates in human plasma: relationship with insulin resistance and associated abnormalities | Q73086790 | ||
| Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis | Q78121947 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nucleoside-triphosphate diphosphatase activity | Q21110155 |
| Ectonucleotide pyrophosphatase/phosphodiesterase 1 | Q21110158 | ||
| idiopathy | Q594841 | ||
| P304 | page(s) | 543-54 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification | |
| P478 | volume | 158 |
| Q34163797 | A new Enpp1 allele, Enpp1(ttw-Ham), identified in an ICR closed colony |
| Q43070609 | A protective role for FGF-23 in local defence against disrupted arterial wall integrity? |
| Q54527062 | ATP acts as a survival signal and prevents the mineralization of aortic valve. |
| Q36642390 | Abnormal Mechanical Loading Induces Cartilage Degeneration by Accelerating Meniscus Hypertrophy and Mineralization After ACL Injuries In Vivo |
| Q36752273 | Advances in defining regulators of cementum development and periodontal regeneration |
| Q34168605 | Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice |
| Q38900801 | Alternatively activated macrophages exhibit an anticalcifying activity dependent on extracellular ATP/pyrophosphate metabolism |
| Q46296200 | Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA. |
| Q37791494 | Articular cartilage calcification in osteoarthritis: insights into crystal-induced stress. |
| Q24812372 | Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population |
| Q54635726 | Association of K121Q polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American adults. |
| Q40437132 | Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. |
| Q53089646 | Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation. |
| Q35768694 | Calcium pyrophosphate dihydrate and basic calcium phosphate crystal-induced arthropathies: update on pathogenesis, clinical features, and therapy. |
| Q35126673 | Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: New developments relevant to the clinician |
| Q61927929 | Chapter 6 Vascular Calcification Inhibitors In Relation To Cardiovascular Disease With Special Emphasis On Fetuin‐A In Chronic Kidney Disease |
| Q24673657 | Characterisation of cartilage intermediate layer protein (CILP)-induced arthropathy in mice |
| Q26748812 | Characterisation of matrix vesicles in skeletal and soft tissue mineralisation |
| Q38646941 | Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification. |
| Q46987166 | Chemical and hormonal determinants of vascular calcification in vitro. |
| Q35097443 | Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders |
| Q46012526 | Congenital Gaucher disease with nonimmune hydrops/erythroblastosis, infantile arterial calcification, and neonatal hepatitis/fibrosis. Clinicopathologic report with enzymatic and genetic analysis. |
| Q35126676 | Crystal deposition disease of the shoulder (including calcific tendonitis and milwaukee shoulder syndrome) |
| Q34222404 | Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1. |
| Q90029208 | Differing calcification processes in cultured vascular smooth muscle cells and osteoblasts |
| Q27343503 | ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy |
| Q58102990 | ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP |
| Q41277036 | Effects of etidronate on the Enpp1⁻/⁻ mouse model of generalized arterial calcification of infancy |
| Q41354101 | Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions |
| Q34825300 | Enpp1: a potential facilitator of breast cancer bone metastasis |
| Q43242721 | Enzyme inhibition, radical scavenging, and spectroscopic studies of vanadium(IV)-hydrazide complexes |
| Q37294492 | Expression of NPP1 is regulated during atheromatous plaque calcification |
| Q58781123 | Extracellular ATP Regulates CD73 and ABCC6 Expression in HepG2 Cells |
| Q35559241 | Extracellular nucleotide metabolism and signaling in the pathophysiology of articular cartilage |
| Q53756234 | Extracellular pyrophosphate in the kidney: how does it get there and what does it do?. |
| Q35087040 | Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle |
| Q37584801 | FGF23 and syndromes of abnormal renal phosphate handling |
| Q41773869 | Generalized Arterial Calcification of Infancy: Fatal Clinical Course Associated with a Novel Mutation in ENPP1. |
| Q35671719 | Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6 |
| Q41986289 | Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin |
| Q55040936 | Generalized arterial calcification of infancy: different clinical courses in two affected siblings. |
| Q55051449 | Generalized arterial calcification of infancy: phenotypic spectrum among three siblings including one case without obvious arterial calcifications. |
| Q34471170 | Generalized arterial calcification of infancy: two siblings with prolonged survival |
| Q82045563 | Genetic and enzymatic analysis for two Japanese patients with idiopathic infantile arterial calcification |
| Q36779445 | Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia |
| Q33352008 | Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel |
| Q28306935 | Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton |
| Q35853942 | Hip geometry variation is associated with bone mineralization pathway gene variants: The Framingham Study. |
| Q34514089 | Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs |
| Q24657630 | Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy |
| Q42113848 | Hypophosphatemic rickets developed after treatment with etidronate disodium in a patient with generalized arterial calcification in infancy |
| Q33474726 | Identification and characterization of novel tissue-nonspecific alkaline phosphatase inhibitors with diverse modes of action |
| Q24631251 | Idiopathic arterial calcification of infancy - a case report |
| Q47591462 | Idiopathic infantile arterial calcification in a 12-year-old girl presenting as chronic mesenteric ischemia: imaging findings and angioplasty results |
| Q34274117 | Idiopathic infantile arterial calcification: Sonographic findings |
| Q41977470 | Idiopathic infantile arterial calcification: a possible cause of refractory cardiopulmonary failure in infancy. |
| Q34519558 | Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up |
| Q34486997 | Idiopathic infantile arterial calcification: imaging evaluation and the usefulness of MR angiography |
| Q34711868 | Idiopathic infantile arterial calcification: the spectrum of clinical presentations |
| Q34506946 | Idiopathic infantile arterial calcification: two case reports, a review of the literature and a role for cardiac transplantation. |
| Q37226131 | Inflammatory cytokines induce a unique mineralizing phenotype in mesenchymal stem cells derived from human bone marrow |
| Q42516251 | Inhibition of arterial medial calcification and bone mineralization by extracellular nucleotides: The same functional effect mediated by different cellular mechanisms |
| Q36688447 | Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis |
| Q53657104 | Isolated pericardial effusion in the human fetus: a report of three cases. |
| Q26766350 | Large animal models of cardiovascular disease |
| Q43843547 | Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression |
| Q90329508 | Magnesium and Anti-phosphate Treatment with Bisphosphonates for Generalised Arterial Calcification of Infancy: A Case Report |
| Q35309274 | Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification |
| Q47647600 | Matrix vesicles from chondrocytes and osteoblasts: Their biogenesis, properties, functions and biomimetic models |
| Q35111872 | Metabolism of extracellular pyrophosphate |
| Q27680880 | Molecular Basis of Purinergic Signal Metabolism by Ectonucleotide Pyrophosphatase/Phosphodiesterases 4 and 1 and Implications in Stroke |
| Q35966637 | Molecular diagnosis of generalized arterial calcification of infancy (GACI) |
| Q34561450 | Molecular-pathogenetic classification of genetic disorders of the skeleton |
| Q42717983 | Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals |
| Q34217171 | Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification |
| Q28833749 | Nanomolar pyrophosphate detection and nucleus staining in living cells with simple terpyridine-Zn(II) complexes |
| Q33291152 | Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification |
| Q35161110 | Npp1 promotes atherosclerosis in ApoE knockout mice |
| Q28214273 | Nucleotide pyrophosphatase gene polymorphism associated with ossification of the posterior longitudinal ligament of the spine |
| Q24301854 | One of two chondrocyte‐expressed isoforms of cartilage intermediate‐layer protein functions as an insulin‐like growth factor 1 antagonist |
| Q35753562 | Osteogenic regulation of vascular calcification: an early perspective |
| Q93182236 | PXE, a Mysterious Inborn Error Clarified |
| Q35525230 | Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification |
| Q48016566 | Persistence of Vascular Calcification after Reversal of Uremia |
| Q44414003 | Phenolic glycosides from Symplocos racemosa: natural inhibitors of phosphodiesterase I |
| Q36943228 | Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification |
| Q34690795 | Phosphate sensing |
| Q26852872 | Phosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models |
| Q35920063 | Phosphate: known and potential roles during development and regeneration of teeth and supporting structures |
| Q105111046 | Phosphodiesterase Inhibitory Coumarinolignoids from Duranta repens |
| Q34769231 | Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification |
| Q35131762 | Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family |
| Q35078539 | Plasma pyrophosphate and vascular calcification in chronic kidney disease |
| Q57070266 | Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy |
| Q35156112 | Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling |
| Q34288709 | Purine receptors modulate chondrocyte extracellular inorganic pyrophosphate production |
| Q35247898 | Recent progress in the treatment of vascular calcification |
| Q36292246 | Regenerating the periodontium: is there a magic formula? |
| Q35699827 | Regulation of cardiovascular calcification |
| Q33727722 | Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia |
| Q48379638 | Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy. |
| Q96109756 | Skeletal abnormalities secondary to antenatal etidronate treatment for suspected generalised arterial calcification of infancy |
| Q51507079 | Smad3 plays an inhibitory role in phosphate-induced vascular smooth muscle cell calcification. |
| Q44838130 | Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1. |
| Q35083898 | Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. |
| Q37218460 | T0901317, an LXR agonist, augments PKA-induced vascular cell calcification |
| Q33911294 | The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells |
| Q34402808 | The bone-vascular axis in chronic kidney disease. |
| Q34821047 | The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification |
| Q33775764 | The role of inorganic pyrophosphate in aortic valve calcification |
| Q36463221 | The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities |
| Q36602795 | The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification |
| Q38151635 | Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors |
| Q58087424 | Tissue Non-Specific Alkaline Phosphatase And Vascular Calcification: A Potential Therapeutic Target |
| Q34035649 | Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization |
| Q37325456 | Treatment of vascular calcification |
| Q38599585 | Treatment with pyrophosphate inhibits uremic vascular calcification |
| Q33603761 | Ultrastructural and biochemical aspects of matrix vesicle-mediated mineralization |
| Q50146523 | Ultrastructure and biological function of matrix vesicles in bone mineralization. |
| Q34165065 | Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease |
| Q41697749 | Upregulation of IGF2 expression during vascular calcification |
| Q28565710 | Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification |
| Q41126480 | Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes |
| Q38671493 | Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem |
| Q37195354 | Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication |
| Q35021536 | Vascular calcification is dependent on plasma levels of pyrophosphate |
| Q28071582 | Vascular calcification: When should we interfere in chronic kidney disease patients and how? |
| Q79744868 | Vascular calcification: not so crystal clear |
| Q38796978 | Zooming in on the genesis of atherosclerotic plaque microcalcifications |
Search more.